| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  InFlectis BioScience Developpment of small molecules to prolong the protective effect of the Integrated Stress Response InFlectis BioScience is a private clinical stage company aiming at targeting and modulating interactions between proteins involved in key human pathophysiological processes. The company is developing small molecule drugs that specifically target the Integrated Stress Response (ISR). Exploiting the ISR’s natural defense offers tremendous potential for the development of a new class of therapies. Led by InFlectis, this area of research is rapidly advancing, resulting in new treatments under development for a variety of disease affecting the central nervous system (CNS), peripheral nervous system (PNS) and … Type: | 2 | 2 | 0 | 11 |
 | DBV Technologies On a mission to advance epicutaneous immunotherapy using our innovative technology platform, ViaskinTM DBV Technologies is a global clinical stage biopharmaceutical company founded by pediatricians who believed that food allergies could one day be treated safely and effectively. We are on a mission to advance epicutaneous immunotherapy using our innovative technology platform, ViaskinTM, to develop treatment options for immunologic diseases with significant unmet medical need. This mission drives our commitment to the advancement of treatments for patients and their families. That is why we are investigating a potential new class of immunotherapy, epicutaneous immunotherapy (EPIT), that aims to re-educate the … | 1 | 1 | 0 | 181 |
 | THERAVECTYS Based in Paris and in the USA, TheraVectys is an immunotherapy company spun off from the Institut Pasteur created in 2005 by Dr. Pierre Charneau. TheraVectys is pioneering the application of novel lentiviral vector technology to address most of unmet and critical medical needs. By creating the only Joint-Laboratory between a private company and the Institut Pasteur in Paris, TheraVectys develops an extensive pipeline of vaccine candidates to drive the widespread treatment and prevention of cancer and infectious diseases. Leveraging our proprietary technology platform, and the extensive virology expertise of the Institut Pasteur, TheraVectys provides a robust and highly effective … Type: | 2 | 2 | 0 | 17 |
 | International Council of Biotechnology Associations (ICBA) The International Council of Biotechnology Associations (ICBA) is a coalition of non-profit, national biotechnology trade associations formed to promote public understanding of, and to advocate for, public policies that support the growth of the innovative biotechnology industries. The ICBA represents the global voice of the industry in international fora with the goal of promoting continued innovation in the human health, agriculture, and industrial and environmental sectors. Markets Represented by the ICBA include: - Argentina - Australia - Belgium - Canada - Costa Rica - Czech Republic - EU - Finland - Germany - Greece - Hungary - India - Italy … Type: | 1 | 1 | 0 | 3 |
 | Lupin There is only one reason why we exist — to treat diseases, to heal and enrich human life. Lupin is a global pharmaceutical company offering Branded and Generic Formulations, Biosimilars and Active Pharmaceutical Ingredients (APIs). Founded over 50 years ago, Lupin today is a significant player in the US, India and Japan and additionally in other counties within APAC, EMEA and LATAM. It holds a global leadership position in Anti-TB and Cephalosporin segments. Today Lupin is focused on building a meaningful pipeline in women’s health in USA, Neurology in Europe and Japan, Cardiac, Diabetes and Respiratory in India and Ophthalmic … Type: | 1 | 1 | 0 | 17,185 |
 | Catalent Pharma Solutions more products. better treatments. reliably supplied. TM Catalent Inc. (NYSE: CTLT), an S&P 500® company, is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs. Catalent supports our partners in introducing 200 new products and manufacturing over 70 billion doses each year. Since becoming a publicly traded company in 2014, we have grown … Type: | 6 | 6 | 0 | 13,864 |
 |  Depixus Depixus® is pioneering a powerful new technology based on magnetic force spectroscopy, that reveals biomolecular interactions. MAGNATM enables researchers to decode disease mechanisms and unlock a faster route to more effective therapies. Our MAGNA technology goes beyond decoding the static genetic code to reveal the dynamics of the genome that control health and disease. Single molecule analysis, RNA Drug Discovery, Protein-protein Interaction Analysis, Biophysics, Drug Discovery, Compound Screening, biomolecular interactions, and interactomics Type: | 1 | 1 | 0 | 63 |
 | NOVAPTECH The Aptamer Expert Company Novaptech develops aptamer-based tools in the frame of technology transfer and innovation projects. Novaptech’s expertise is focused on the identification and the characterization of aptamers for biotechnological development of analytical and diagnostic aptamer projects. Novaptech develops collaborative projects or service agreements with academic laboratories and R&D department of companies. Novaptech works in close association with Dr. Toulmé ’s team, an academic laboratory (Inserm U1212, Bordeaux) which has more than 26 years of experience in aptamer selection. Research and Development and Therapeutics and Diagnostics Type: | 1 | 1 | 0 | 11 |
 | DIVERCHIM CDMO API manufacturer of small quantities and GMP excipients supplier Founded in 2000, DIVERCHIM is the leading French company for organic synthesis of original molecules bringing its customers a top level expertise. DIVERCHIM is a Contract Research Organisation (CRO) in organic chemistry. Our teams combine experience in drug discovery and process development, medicinal chemistry, parallel synthesis, biochemical tools and fine chemicals to deliver you with unique chemistry solutions to achieve your requirements. Diverchim specifies in complex multi-steps synthesis, low temperature chemistry, asymmetric, organometallic, cyclopropane, pyrrolidine, oxetane chemistry... Besides Diverchim can scale-up existing processes or develop a new process for existing products. … Type: | 1 | 1 | 0 | 45 |
 | ALLIS-NA | Alliance Innovation Santé Nouvelle-Aquitaine [Automatic translation follows] Let's facilitate the emergence of health solutions together The Health Innovation Alliance, ALLIS-NA, aims to bring together all industrial, academic, institutional and hospital forces around common values for the benefit of patients. Our missions: Represent and Lead the Health Ecosystem in New Aquitaine to support its economic and territorial development: - Be a “partner” for HEALTH innovation professionals - Facilitate connections and alliances - Promote and represent professionals in the sector - Accelerate value creation and business growth Do not hesitate to contact us and join the network! Health, Biotechnology, Medtech, Medical devices, Pharma, life sciences, Healthcare … Type: | 35 | 16 | 0 | 7 |
 | Calliditas Therapeutics Pioneering treatments for rare diseases. We harness scientific & commercial expertise to improve the lives of patients. Calliditas is a specialty pharmaceutical company developing high value products for patients with significant unmet medical needs. With a highly experienced, dynamic management team, Calliditas draws on its extensive experience of pharmaceutical development and marketing to efficiently identify and progress valuable and de-risked products. Type: | 5 | 2 | 0 | 220 |
 | CardioRenal Digital therapeutics for chronic cardiovascular disease CardioRenal is a company dedicated to improving the quality of treatment for heart failure patients through the use of state-of-the art technology (expert systems, real-time diagnosis, microfluidics, etc.) combined with top medical expertise. CardioRenal est une société qui développe une solution de télé-médecine qui permet de mesurer des biomarqueurs chez un patient à domicile et ainsi d'adapter en temps réel la thérapie en fonction de l'état du patient. Nous ciblons les patients insuffisants cardiaques. Grâce à un accord de licence avec un laboratoire pharmaceutique nous visons une commercialisation à grande échelle à relativement court … Type: | 5 | 5 | 0 | 10 |
 | BeiGene BeiGene is a global oncology company that is discovering and developing innovative treatments that are more accessible and affordable to cancer patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need them. Our growing global team of more than 10,000 colleagues spans five continents, with administrative offices in Basel; Beijing; and Cambridge, U.S. To learn more about BeiGene, please visit www.beigene.com and follow us on LinkedIn, X (formerly known as Twitter) and … Type: | 1 | 1 | 0 | 3,896 |
 | Idorsia Pharmaceuticals Ltd Reaching out for more! The purpose of Idorsia is to discover, develop, and commercialize innovative medicines to help more patients. We have more ideas, we see more opportunities, and we want to transform the horizon of therapeutic options. In order to achieve this, we will develop Idorsia into a leading biopharmaceutical company, with a strong scientific core. Headquartered in Switzerland – a biotech-hub of Europe – Idorsia is a high-potential biopharmaceutical company, specialized in the discovery, development and commercialization of innovative small molecules, with the aim of transforming the horizon of therapeutic options. See our LinkedIn community guidelines: https://www.idorsia.com/documents/com/policies-charters/idorsia-linkedin-community-guidelines.pdf Idorsia … Type: | 1 | 1 | 0 | 1,158 |
 | Dyameo [Automatic translation follows] Dyameo is a research & development in the field of medical devices which designs probes to aid in the diagnosis of cancer cells in-vivo. This medical device allows us to answer the question: “Are these cells cancerous?”, in a simple, clear and instantaneous way. This breakthrough solution proposes to discriminate cancer cells at an early stage, during endoscopic examinations. Medical devices, MedTech, and In-vivo cancer diagnosis assistance Type: | 2 | 2 | 0 | 8 |
 | POXEL Poxel is a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare disorders. Poxel has clinical and earlier-stage programs from its adenosine monophosphate-activated protein kinase (AMPK) activator and deuterated TZD platforms targeting chronic and rare metabolic diseases. For the treatment of NASH, PXL065 (deuterium-stabilized R-pioglitazone) is in a streamlined Phase 2 trial (DESTINY1). PXL770, a first-in-class direct AMPK activator, has successfully completed a Phase 2a proof-of-concept trial for the treatment of NASH, which met its objectives. For the rare inherited metabolic disorder, adrenoleukodystrophy (ALD), the company intends to initiate … Type: | 2 | 2 | 0 | 26 |
 | Swiss Biotech Association The central resource for the Swiss biotech industry Founded in 1998, the Swiss Biotech Association represents the interests of the Swiss biotech industry. To support its members in a competitive market, the Swiss Biotech Association works to secure favorable framework conditions and facilitate access to talents, novel technologies and financial resources. To strengthen and promote the Swiss biotech industry, the Swiss Biotech Association collaborates with numerous partners and life science clusters globally under the brand Swiss BiotechTM. Type: | 4 | 4 | 0 | 18 |
 | Académie Nationale de Chirurgie [Automatic translation follows] The National Academy of Surgery wants to contribute to meeting the public health challenges we face. Role and objectives of the National Academy of Surgery Moral responsibility in all matters concerning surgeryGuardian of its history Witness its evolution Guarantor of its ethics Careful and rigorous evaluation of the development of technical aspects of the surgical art and their changes Definition of good surgical practices: references, recommendations, strategies Control of the conditions of the specific exercise of surgery Appreciation of the training and recruitment of surgeons Type: | 18 | 7 | 0 | 62 |
 | Auriga Partners [Automatic translation follows] Supporting those who challenge the status quo Since its creation in 1998, Auriga Partners has been a pioneer in venture capital investment in France and Europe with more than 120 companies financed in IT and Life Sciences. Because the innovation environment is ever more complex to understand, Auriga Partners is now implementing a multi-specialist investor strategy whose purpose is to rely on talents, business expertise and ecosystems. to create and develop specialized thematic funds. With the ambition to generate maximum value for entrepreneurs and ultimately for investors. The funds are deployed in capital on start-ups / scale-ups … Type: | 5 | 5 | 0 | 11 |
 | Merck At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and … Type: | 15 | 14 | 0 | 67,800 |
 | Octapharma Our passion drives us to provide new health solutions advancing human life Headquartered in Lachen, Switzerland, Octapharma is one of the largest human protein manufacturers in the world, developing and producing human proteins from human plasma and human cell lines. Octapharma employs nearly 12,000 people worldwide to support the treatment of patients in 118 countries with products across three therapeutic areas: Immunotherapy, Haematology and Critical Care. Octapharma has seven R&D sites and five state-of-the-art manufacturing facilities in Austria, France, Germany and Sweden, and operates more than 195 plasma donation centres across Europe and the US. Octapharma has 40 years of … Type: | 3 | 3 | 0 | 2,431 |
 | AIA AIA Group Limited and its subsidiaries (collectively “AIA” or the “Group”) comprise the largest independent publicly listed pan-Asian life insurance group. It has a presence in 18 markets – wholly-owned branches and subsidiaries in Mainland China, Hong Kong SAR(1), Thailand, Singapore, Malaysia, Australia, Cambodia, Indonesia, Myanmar, New Zealand, the Philippines, South Korea, Sri Lanka, Taiwan (China), Vietnam, Brunei and Macau SAR(2), and a 49 per cent joint venture in India. In addition, AIA has a 24.99 per cent shareholding in China Post Life Insurance Co., Ltd. The business that is now AIA was first established in Shanghai more than a … Type: | 2 | 2 | 0 | 44,542 |
 | EVerZom Revolutionizing healthcare with exosomes focusing on gastrointestinal, liver and kidney regeneration EverZom is an exosome biotech company developing treatments for digestive tissue healing like Crohn's fistula and organ regeneration like the kidney and the liver. Founded in 2019, EverZom is positioned to become the leader of exosome therapeutics, the next wave of innovation for the biotech industry. Exosomes, small vesicles secreted by cells, are increasingly recognized as potent agents for intercellular communication and play a crucial role to treat a wide range of diseases. Winner of the European EIC Accelerator Program, EVerZom aims to be the upcoming pioneer in this … Type: | 12 | 12 | 0 | 18 |
 | Orchard Therapeutics Dedicated to transforming the lives of patients with severe and other genetic diseases through innovative gene therapy. At Orchard Therapeutics, our vision is to end the devastation caused by genetic and other severe diseases. We aim to do this by discovering, developing and commercializing new treatments that tap into the curative potential of hematopoietic stem cell (HSC) gene therapy. In this approach, a patient’s own blood stem cells are genetically modified outside of the body and then reinserted, with the goal of correcting the underlying cause of disease in a single treatment. In 2018, the company acquired GSK’s rare disease … Type: | 2 | 2 | 0 | 204 |
 | Invectys Invectys a biopharmaceutical company focused on the development of innovative immunotherapy approaches to treat cancers Invectys, Inc. is a privately owned clinical-stage company, headquartered in Houston, Texas, which is developing a new generation of First-in-Class products for cancer patients. Invectys has two wholly owned subsidiaries, Invectys, SAS (Paris) which is focused on scientific research and innovation and Invectys USA, Inc. (Houston) which is directing the clinical development of the Company’s lead HLA-G product. Since 2010, Invectys has raised over $60 million in private funds to develop its two innovative platforms of immunotherapy products which target “universal” tumor antigens. oncology, immunotherapy, … | 1 | 1 | 0 | 24 |
 | Innoskel Developing novel therapies for rare bone diseases Innoskel is a pioneering platform biotechnology company developing therapies for rare bone diseases. Innoskel's first asset is a treatment option for a group of rare skeletal disorders collectively known as type 2 collagenopathies, the most severe of which with symptoms present from birth is Spondyloepiphyseal Dysplasia congenita (SEDc), the second leading cause of dwarfism worldwide. Innoskel’s lead gene therapy asset for SEDc has demonstrated good efficacy in proof-of-concept studies. The company’s fundamental mission is to improve the lives of patients living with rare bone disorders and to answer their unmet needs, keeping their … Type: | 7 | 6 | 0 | 22 |
 | Rarecells Detect and defeat cancer from its start through a simple blood draw. Rarecells develops and commercializes the ISET technology to isolate Circulating Cancer Cells for early cancer diagnosis and medical research. Rarecells® Diagnostics was created in 2010 by Patrizia Paterlini Brechot, Professor of Cell Biology and Oncology, in order to make the scientific and technological advances developed by her team available to research teams and patients. Rarecells® Diagnostics’ core product is the patented ISET® (Isolation by SizE of Tumor cells) Technology. Rarecells® Diagnostics has the exclusive license of patents belonging to the French Public Institutions University Paris Descartes, Assistance Publique … Type: | 1 | 1 | 0 | 22 |
 | I.Ceram [Automatic translation follows] Created in 2005 at the Ester technology park in Limoges, our company specializes in the design, manufacturing and marketing of innovative orthopedic implants for the entire human body. Manufacturing and distributing all of its implants, I.Ceram is developing in France (directly with French hospitals and clinics) and internationally (England, Belgium, Costa Rica, Spain, Italy, Czech Republic, etc.). ). innovation, implants, France, International, Orthopedics, Ceramics, and Ceramic sternum Type: | 3 | 3 | 0 | 19 |
 | AVALUN Connected Biology Everywhere. While AVALUN's technology has enabled us to design a portable mini-lab that you can hold in your hands, our aim is, above all, to leave you free to invent the care pathways that go with it. New care pathways freed from the constraints of place and time, so that you can use every minute saved to take better care of others, or take better care of your health. The ultra-compact design of our LabPad range focuses on portability and accessibility. Since the daily life of each patient should be the place where everything happens, the LabPad has … Type: | 3 | 3 | 0 | 26 |
 |  InVenis Biotherapies Platelet-derived Regenerative Therapy for CNS Disorders InVenis Biotherapies is a biotech compagny, spin-off from academic laboratory U1172 and Taipei Medical University, developping innovative regenerative therapies based on blood platelet. Thanks to the high therapeutic potential of our product, we target the most severe diseases involving cell death, as the amyotrophic lateral sclerosis. Type: | 4 | 4 | 0 | 2 |
 | COZii [Automatic translation follows] Created in 2015, COZii aims to become the leader in indoor navigation and geolocation of people and objects inside buildings. After several years of R&D to build an intuitive, flexible and efficient application, the efforts culminated in 2018 with the release of the COZii application. A multi-technology application Thanks to a combination of all existing geolocation technologies, COZii adapts to all situations and all budgets. Also able to rely on existing infrastructure. The precision can reach one meter. On the user side, the mobile application is available on the stores for free download. On the administrator and … Type: | 3 | 3 | 0 | 3 |
 | IVANAE Medical A leap forward in respiratory care IVANAE is a medical device company providing an innovative technology for contactless respiratory monitoring. Our mission is to: • improve clinical prognosis in patients with respiratory diseases • improve patients’ care and safety by adapting High-Flow Nasal Cannula (HFNC) therapy to the patient’s needs • help health care providers diagnose by offering continuous measurement of respiratory parameters Respiratory monitoring, Hospital healthcare, Oxygen therapy, Medical device, Surface imaging, Depth sensors, Artifical intelligence, and Respiratory care Type: | 9 | 6 | 0 | 2 |
 | Cardiabase Based in France, Cardiabase is a worldwide cardiac core lab specialized in data acquisition, processing, analysis, reporting and archival for digital and paper 12-Lead ECG, stress electrocardiograms, holter monitoring and ambulatory blood pressure monitoring since 1999. As the result of ten years of continuous research and innovation in ECG data analysis techniques, Cardiabase is today a full-service global CRO (Clinical Research Organization). With proven expertise in supporting global clinical trials for pharmaceutical companies and bringing more than 4 years of experience in event adjudication in major industry-sponsored clinical trials, Cardiabase has successfully coordinated management of thousands of outcome events. Cardiabase … Type: | 2 | 2 | 0 | 12 |
 | Aliae Aliae develops digital therapeutics and dialogs with patients, to improve mental health and quality of life Aliae is a French Health Tech founded in 2017. Our commitment to health is to ensure a continuous assessment of patients’ quality of life and mental health, with a simple and empathetic dialogue that comes naturally in their daily life. We work with medical experts and engineers to mobilize natural language processing and machine learning for personalized, motivating dialogs. Our first application is dedicated to chronic pain. ALIAE is based in Nancy France (Grand East). NLP, Chatbot, Machine Learning, ePRO, e-Health, digitaltherapeutics, and Mental … Type: | 2 | 2 | 0 | 9 |
 | SpacePharma Bring your research idea and we will make it happen SpacePharma is a unique powerhouse offering an affordable and accessible microgravity research, together with true innovation to R&D pipelines. Our mission is to become a world leader in providing simplified and valuable, end-to-end microgravity services and solutions for research. Microgravity is a disruptive opportunity for several major sectors: pharmaceuticals, biotechnology, chemistry and materials science. It provides companies and researchers with the ability to accelerate discovery processes for new drugs and vaccines, develop new crystals and materials and accelerate the study of human genome and origin of diseases. The potential scientific, … Type: | 5 | 5 | 0 | 19 |
 | Stromacare SAS Stromacare is a pioneer in tumoral stroma immuno-modulation and develops a therapeutic mAb for the treatment of cancers StromaCare is opening a new therapeutic avenue by targeting the tumoral Stroma, which is known to play a key role in several solid cancers, with the objective to be essential in the numerous anticancer protocols of treatment. Stromacare won the Beatrice Denys Foundation 2021 Prize (Foundation for Medical Research). The company is located in Lyon, France. oncology and monoclonal antibody Type: | 3 | 3 | 0 | 15 |
 | MCE CARREL AVOCATS Creative legal services for the protection, development and transfer of your innovations. A Boutique law firm in Paris and Geneva, we provide creative legal services for the protection, development and transfer of your innovations. Technology Transfer and Licensing Intellectual Property and Data Privacy Software and Tech Strategic Development Litigation, Arbitration & Mediation Business and Corporate Law intellectual property, techtransfer, biotech, licensing, startups, chemistry, medtech, lawyer, Research, IP, patent, and copyright Type: | 3 | 1 | 0 | 14 |
 | Nūmi (ex-MUMilk) At Nūmi, we're on a mission to redefine infant health through groundbreaking research and innovations. We’re working to recreate the magic of in vivo breast milk in vitro, offering parents a natural choice when breastfeeding isn’t an option. Type: | 5 | 5 | 0 | 11 |
 | Le Vinatier - Psychiatrie Universitaire Lyon Métropole [Automatic translation follows] Referral establishment in psychiatry and mental health psychiatry and mental health Type: | 5 | 5 | 0 | 914 |
 | Urgo Medical Make a difference by helping healthcare professionals heal patients Urgo Medical is the wound-healing division of URGO group. Every day our 1600 employees are passionate about creating, developing and promoting highly innovative dressings and global solutions to heal people suffering from wounds. Our mission, as The Healing Company, is to make a significant difference for patients, healthcare professionals and the healthcare systems. In order to fulfil our mission: • Patient is at the heart of everything we do. • We keep innovating to develop the best in class solutions. • We have a pioneer and entrepreneurial mindset and we dare … Type: | 1 | 1 | 0 | 591 |
 | MindPulse FR [Automatic translation follows] Developed by IT'S BRAIN It’s Brain develops and provides cognitive clinicians with innovative digital tools to improve the assessment of their patients. Sandra Suarez, doctor in neuroscience and neuropsychologist, felt when starting her work as a clinician the need for neurocognitive tests more in line with the progress of neuroscience and technologies, which led to the design of Mindpulse. The use of digital technology allows a rapid and precise assessment of the patient's attention and decision-making abilities, independent of the person's culture. MindPulse qualifies and quantifies attentional and executive functions, as well as the response to difficulty. … Type: | 2 | 2 | 0 | 7 |
 | BIOCODEX Healthcare with passion and conviction Biocodex is a French pharmaceutical company founded in 1953 to develop and market the world’s first probiotic yeast strain, Saccharomyces boulardii CNCM I-745®. Today, Biocodex focuses its business on three main areas: Microbiota care; Women’s health; Orphan diseases. With more than 1,600 employees, Biocodex generated net revenues of above €500 million in 2023, including 1/3 in France and 2/3 internationally. The group is present in more than 100 countries through wholly owned subsidiaries in 16 countries and a network of distributors worldwide. To report quality complaint(s) or adverse event(s) related to Biocodex products please visit … Type: | 6 | 5 | 0 | 1,418 |
 | Music Care CARE COMPOSER: for a significant reduction in pain, anxiety and the use of medication MUSIC CARE® develops innovative tools for the prevention and management of pain, stress, anxiety and depression. The MUSIC CARE® health device is a turnkey therapeutic management offer validated by a series of controlled clinical studies. Accessible to all professionals, our assistance and support solutions open up innovative perspectives for the world of health and well-being. MUSIC CARE® is now present in numerous hospitals, private clinics, senior citizens' homes and spa centers. Our strengths * Effectively manage pain*, anxiety, stress and depression * Significantly reduce drug consumption … Type: | 3 | 3 | 0 | 14 |
 | MindHealth Our differentiated physician-led psychiatric practice aims to provide innovative, evidence-based care. We focus on physician and staff well-being to provide the best therapeutic alliance with our clients creating a values-driven mental health and technology platform. We would love to hear from you if you are a psychiatrist or advanced practitioner. Contact us at info@mindhealthpsych.com psychiatry and Mental Health Type: | 2 | 2 | 0 | 4 |
 | lifeina Creators of the world's smallest fridge, designed to keep your medication at a constant temperature wherever you may go. Our future is one in which the lives of medication users are not dictated by their health. A future where you have the freedom to take control by using the right tools. ___ Without flawless execution, ingenious ideas might as well remain dreams. We honour our reputation and strive to be industry leaders. In doing so, we keep our small team flexible enough to listen and respond to your needs directly. So, when you speak to one of us, you’re speaking … Type: | 5 | 4 | 1 | 7 |
 | Tidjee [Automatic translation follows] Build. Transform. Innovate. Tidjee is a consulting firm specializing in transformation and financing innovation. We support managers and their teams in their decisions and we work alongside them to secure execution. Within our studio we work in symbiosis with our ecosystem to launch projects of interest in the fields of training, automation, and artificial intelligence. Transformation, external CFO, financial management, strategic consulting, Financial Consulting and Diagnostics, CFO part time, cash management, CSR, sparring partner, and financing Type: | 3 | 2 | 1 | 3 |
 | ABLE - Association of Biotechnology Led Enterprises The Collective Face of the Indian Biotechnology Industry Association of Biotechnology Led Enterprises - ABLE is a not-for-profit pan-India forum that represents the Indian Biotechnology Sector. It was launched in April 2003, after industry leaders felt a need to form an exclusive forum to represent the Indian Biotechnology Sector. ABLE has members from all across India representing all verticals of the sector like agribiotech, bio-pharma, industrial biotech, bioinformatics, investment banks and Venture Capital firms, leading research and academic institutes and law firms and equipment suppliers. The primary focus of ABLE is to accelerate the pace of growth of the Biotechnology … Type: | 2 | 1 | 1 | 17 |
 | AERIAL COBOTICUS SAS [Automatic translation follows] Heavy Duty UAV. Quick Access, Faster Work AERIAL COBOTICUS specializes in the design and construction of Aerial Machines: drones dedicated to intensive work in the industrial field such as concrete preparation, material projection (resins, flocking, paints) and cleaning / stripping (High and Very High Pressure) as well as the rapid transport of loads to replace cranes. Drones, Telemanipulation, Industry, and Aeronautics Type: | 6 | 2 | 1 | 8 |
 | Seagen Targeting Cancer. Transforming Therapies. Seagen is where revolutionary science meets transformative cancer therapy. Seagen is committed to advancing late-stage clinical trials and expanding the development of its portfolio both in and outside the U.S. to better the health of people with cancer. We are dedicated to improving patient outcomes through advanced antibody-drug conjugate technology designed to deliver cell-killing agents directly to tumor cells. We are focused on discovering, developing, manufacturing and commercializing targeted cancer therapeutics, with antibody-drug conjugates (ADCs) at our core. We work together with urgency to improve and extend the lives of people living with cancer. Our industry-leading … Type: | 3 | 2 | 1 | 2,292 |
 | Limatech [Automatic translation follows] Safe & Light Energy for Aviation Limatech offers 28V Lithium batteries certified for aeronautics. These new batteries provide weight savings, longer longevity and better availability than old lead and Nickel-Cadmium technologies. Lithium Batteries, Defense, and Aeronautics Type: | 28 | 10 | 1 | 44 |
 | Advanced Accelerator Applications We are your partner of choice in Europe for precision diagnostic solutions for positron emission tomography (PET) imaging – a cornerstone of personalized nuclear medicine. Our core mission is to develop, manufacture, test, and timely supply radiopharmaceutical products for patients in need, with a primary focus on oncology, while expanding our network and expertise into other disease areas, such as neurology, as we continue to unlock the potential of molecular imaging in nuclear medicine. Type: | 4 | 2 | 1 | 964 |
 | Axoltis Pharma The CNS Regeneration Company Axoltis pharma is a biopharmaceutical company dedicated to develop a first-in-class disease-modifying drug to treat patients with neurodegenerative or traumatic neurological disorders with high unmet medical needs. Our innovative approach: combining Preventative, Neuroprotective, Regenerative & Remodeling properties in a single drug, as the key to cure complex neurological disorders. Our products are first-in-class multifunctional peptides with high potential in many CNS disorders. neurodegenerative diseases, neurodegeneration, spinal cord injury, peptide, neuroprotection, neural repair, regeneration, drug, biotechnology, pharma, CNS, neurology, ALS, Parkinson, and Multiple Sclerosis Type: | 3 | 2 | 1 | 11 |
 | BIOSYNEX Theradiag Innovation for Biotherapies Capitalizing on its expertise in the distribution, development and manufacturing of in vitro diagnostic tests, Theradiag innovates and develops theranostics tests (combining treatment and diagnosis) that measure the efficiency of biotherapies in the treatment of autoimmune diseases and cancer. Theradiag is thus participating in the development of customized treatment, which favors the individualization of treatments, the evaluation of their efficacy and the prevention of drug resistance. Theradiag notably markets the Lisa Tracker® range (CE marked), which is a comprehensive multiparameter theranostic solution for patients with autoimmune diseases treated with biotherapies. The Company is based in Marne-la-Vallée, near … Type: | 1 | 0 | 1 | 60 |
 | EURAXI Conception et réalisation de vos projets d'Etudes Cliniques, Registres, Programmes d'Accès précoces, Home Nursing 🚀✨ Euraxi (CRO) is a project management specialist in the health sector, assisting clients with their projects since 1986. Our organisation and service offer have been perfectly tailored to meet the precise needs of our clients. We can take on all or part of your operations thanks to our multidisciplinary team. This team is organised into specialised units and is guided by the risk management and quality procedures inherent to the requirements of your projects. - Clinical Operations - Data Management, eTools & Statistics - Medical … Type: | 1 | 1 | 1 | 115 |
 | Inotrem Control innate immunity Inotrem is a biotechnology company specialized in immunotherapy for acute inflammatory syndromes, such as septic shock. Founded in 2013, with offices in Paris and a technology center in Nancy (France), the company has developed a new concept of immunomodulation that targets the TREM-1 pathway to control unbalanced inflammatory responses. Leveraging its proprietary technology platform, Inotrem has developed the first-in-class TREM-1 inhibitor, nangibotide, with applications in a number of therapeutic indications such as septic shock or myocardial infarction. Next to acute inflammatory syndromes, Inotrem is also developing a program targeting chronic inflammatory diseases. Tags: FrenchTech120 Type: | 7 | 6 | 1 | 34 |
 | HighLife Transeptal Mitral Valve Replacement HighLife is a trans-catheter mitral valve replacement company committed to bringing the best minimally invasive technology to the patients. | 3 | 1 | 1 | 74 |
 |  Amolyt Pharma Advancing peptides for the treatment of rare endocrine and related diseases Amolyt Pharma is building on its team’s established expertise to deliver life-changing treatments to patients suffering from rare endocrine and related diseases. Amolyt Pharma’s portfolio includes eneboparatide (AZP-3601), a long-acting PTH1 receptor agonist as a potential treatment for hypoparathyroidism, and AZP-3813, a peptide growth hormone receptor antagonist for the potential treatment of acromegaly. Amolyt Pharma aims to further expand and develop its portfolio by leveraging its global network in the field of endocrinology and with support from a strong syndicate of international investors. Hypoparathyroidism, Endocrinology, Metabolic Disease, Therapeutic Peptides, … Tags: FrenchTech2030 Type: | 9 | 8 | 1 | 61 |
 | Crossject Expert des médicaments d'urgence auto-administrés Crossject SA (Euronext: ALCJ; www.crossject.com) is an emerging specialty pharma company based in France and the U.S. It is in advanced regulatory development for ZEPIZURE®, an epileptic rescue therapy, for which it was awarded a $60 million contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA). ZEPIZURE® is based on the Company’s award-winning needle-free autoinjector ZENEO®, designed to enable patients and untrained caregivers to easily and instantly deliver emergency medication via intramuscular injection on bare skin or even through clothing. The Company’s other products in development include rescue therapies for allergic shocks, adrenal … Type: | 16 | 7 | 1 | 94 |
 | Thess Corporate [Automatic translation follows] 1st solution for security and real-time adjustment of drug delivery Medical device for multi-pathology medical remote monitoring & Connected and secure medical device for taking medication Type: | 11 | 1 | 1 | 30 |
 | VistaCare Medical For a good wound bed preparation VistaCare Medical develops, manufactures and distributes medical devices for the treatment of complex wounds, whether acute or chronic. We aim to contribute with health professionals to improve the lives of patients suffering from complex wounds that are difficult to treat with standard therapies. Our current product on the market VistaCare One is showing an improvement in the debridement and vascularization steps of wound healing process making it an ideal wound bed preparation companion product for grafting. The company is developing an Homecare version - VistaCare Nomad - which will bring an expert device for … Type: | 3 | 3 | 1 | 5 |
 | Systematic Systematic A/S, established in 1985, develops software and system solutions to customers in both the public and private sector. A common feature of these customers is a need to integrate, compare and analyse large volumes of complex data, and to generate an overview that allows decision-making based on a solid foundation, often in critical situations. Today, the company is the largest privately-owned software company in Denmark, with solutions sold to customers in 50+ countries. More than 500,000 people worldwide now use Systematic solutions and services. The company has approximately 1000+ employees and is headquartered in Aarhus, Denmark, with offices in … Type: | 6 | 4 | 1 | 1,179 |
 | StemInov Births can save lives StemInov is a French Drug Discovery company working on a innovative cell based therapy in immunology Type: | 13 | 10 | 1 | 4 |
 | Cerba Research At Cerba Research we provide world-class clinical research to help life science companies successfully develop the predictive and precision medicines of the future and help people live healthier lives. We are committed to delivering the next generation of healthcare by transforming research and advancing health together. We support you with industry-leading excellence in oncology, virology, vaccine development, immunology, and cell and gene therapy, together with world-class deep specialty testing, from next generation sequencing to flow cytometry, molecular diagnostics, IHC & and spatial Omics, and bioinformatics. We are committed to helping you deliver the next generation of human-centric healthcare, by transforming … Type: | 3 | 2 | 1 | 558 |
 | ARGOBIO Turning cutting-edge innovations into breakthrough Biotech companies Argobio is a start-up studio dedicated to novel therapeutics aiming to nurture and launch breakthrough Biotech companies. Argobio sources innovative early-stage projects from renowned European academic research institutions with the objective of incubating these projects before company creation. The focus is on rare diseases, neurological disorders, oncology, and immunology. The studio also look to develop promising platform technologies for therapeutic products. Argobio was initiated by Kurma Partners, Bpifrance, Angelini Pharma, Evotec and Institut Pasteur who have committed 50M € to Argobio. Type: | 2 | 1 | 1 | 20 |
 | MY HOSPITEL [Automatic translation follows] Hospital care, nights in a hotel. My Hospitalel publishes the first management platform for the hotel-patient system. Thanks to its solution, it facilitates the sending of patients eligible for HTNM* to the hotel, without administrative overhead for hospital staff. Our digital solution adapts to all types of establishments at no additional cost. Our digital tool allows beds to be quickly reallocated by eliminating unnecessary overnight stays and thus limits the rescheduling of operations. My Hospitel increases the reception capacity of hospital establishments while ensuring patient comfort during their care journey. The patient becomes an actor in his … Type: | 13 | 6 | 1 | 41 |
 | inspiring-health GmbH "We cannot direct the wind, but we can adjust the sails." - Aristotle inspiring-health GmbH is committed to solutions within the healthcare industry that target ideal synergies between medicine and economy. We support diagnostic, medical technology and pharmaceutical companies to introduce their innovations into the German market and into the German reimbursement system. On behalf of medical societies, we verify whether their performance is correctly depicted and remunerated within the DRG system. We support hospitals with their infection management through the use of routine data. Legal Notice: https://www.inspiring-health.de/en/legal-notice.html Data-Protection-Declaration: https://www.inspiring-health.de/en/data-protection-declaration.html Market Access Strategy and Innovation Support, Economic Studies, Intelligent Apps, … Type: | 2 | 1 | 1 | 11 |
 | MJ INNOV [Automatic translation follows] Offer moments of happiness to vulnerable people (cognitive disorders/disability) thanks to the Tovertafel! MJ INNOV, a social enterprise created in 2018, offers you an innovation in care that brings moments of happiness for people living with neuro-cognitive disorders or with specific needs as well as all those around them. The Tovertafel is a fun care innovation that connects its users with each other and with their environment, while stimulating movement. These magic games were developed in the Netherlands (following 5 years of scientific research), specifically for these groups of people. The Tovertafel can be used both individually … Type: | 2 | 1 | 1 | 25 |
 | Ancim - Association Nationale des Cadres de Santé [Automatic translation follows] Are you a Health Executive, Acting-Function or Student Health Executive? Join us and join the association! . Type: | 3 | 1 | 1 | 12 |
 | ESA BSGN | Business in Space Growth Network Join Europe's leading Network for Commercialisation in Exploration. The BSGN is the right place for you if you are interested in 👇🏻 🌟 Business opportunities in the emerging LEO and Lunar Economy 🌟 Development and usage of commercial services, modules, stations and missions in LEO, on or around the Moon and Mars 🌟 Making use of microgravity to boost your commercial R&D and product development, especially in Agriculture, Food, Life Sciences and Materials 🌟 In-Orbit Manufacturing 🌟 Space Resources and In-Situ Resource Utilisation 🌟 Innovative ideas related to space exploration and commercialisation Interested? Send an email to BSGN@ESA.INT with your … Type: | 2 | 1 | 1 | N/A |
 | Nosopharm Nosopharm is an innovative biotechnology company headquartered in Lyon (France) and specialized in the research and development of new molecules to combat antimicrobial resistance (AMR). The mission of Nosopharm is to discover and develop novel first-in-class anti-infectives addressing unmet medical needs. The innovative anti-infective drug discovery platform developed by Nosopharm is based on the therapeutic exploitation of a very original bioresource: the bacterial genera Xenorhabdus and Photorhabdus. Anti-Infectives, Drug Discovery, Antibiotics, and Microbiology Type: | 12 | 10 | 2 | 7 |
 | Ehtrace [Automatic translation follows] Our expertise in mobile traceability of medical devices serving healthcare establishments. Expert in DM/DMI traceability The strength of our team: delivering innovative, adapted, easy-to-use and optimized technological solutions with significant development capacity. Our in-depth knowledge of the field and the issues of the health sector strengthens us in the choices of functionalities and ergonomics of developments. For several years, the mastery and use of rapid and reliable development techniques, such as the Agile method, has also been an asset for our future development. Our ambition : create the ultimate solution in terms of innovation and technology and … Type: | 4 | 2 | 2 | 23 |
 | IHU LIRYC - Heart rhythm disease Institute 🔬 Liryc is an international research, clinical and teaching centre focusing on heart rhythm diseases. The Heart Rhythm Disease Institute (French: L'Institut des maladies du RYthme Cardiaque), is one of 6 French university hospital institutions created in 2011 as part of the investments in the future program ("Investissements d'avenir") to boost medical research and innovation. This institute, created by Professor Michel Haissaguerre along with cardiology teams of the University Hospital of Bordeaux, unites multiple specialties around cardiac electrophysiology from research on ionic channels (microgenerators producing electric flows in cells) to whole heart and patient care. LIRYC is a basic research, … Type: | 22 | 5 | 2 | 98 |
 | AusBiotech Australia's Biotechnology Organisation AusBiotech is Australia's Biotechnology Industry Organisation, which represents over 3,000 members working in life sciences, including therapeutics, medical technology (devices and diagnostics), digital health, food technology and agricultural sectors. AusBiotech is dedicated to the development, growth and prosperity of the Australian Biotechnology Industry, by providing initiatives to drive sustainability and growth, outreach and access to markets, and representation and support for members nationally and around the world. AusBiotech has representation in each Australian state providing a national network to support members and promote the commercialisation of Australian bioscience in the national and international marketplaces. The structure is … Type: | 4 | 2 | 2 | 53 |
 | hollandbio Biotech makes life better The mission of hollandbio, the Dutch biotech industry association, is to maximize the contribution of biotech innovations to our society’s health and sustainability. We represent, support and connect an active, privately funded, and rapidly growing community of more than 270 member companies. Our members are a reflection of the biotech sector: from start-ups and SMEs to large companies and multinationals, active in fields ranging from healthcare and agri-food to biobased applications and cultured meat. By tackling the obstacles that hinder our frontrunners, hollandbio aims for progress - even when that means challenging the status quo. Advocacy, … Type: | 6 | 3 | 2 | 22 |
 | AfricaBio AfricaBio is an independent, non-profit biotechnology stakeholders association. Its key role is to provide accurate information and create awareness, understanding as well as knowledge on biotechnology and biosafety in South Africa and the African region. | 3 | 1 | 2 | 17 |
 | Kayentis Simplify your clinical trial experience Kayentis, a global provider of eCOA (electronic Clinical Outcome Assessment) and Decentralized Clinical Trial solutions (DCTs), helps pharma, biotech and CROs bring simplicity, efficiency and quality to the collection of clinical trial data from both patients and sites. Since 2005, Kayentis has been active in clinical development, with a strong specialization in eCOA solutions for phases I-IV across a broad range of therapeutic areas. Over the years, it has developed a full range of services and has enlarged its portfolio beyond eCOA solutions to support the new normal of decentralized and hybrid trials. The company … Type: | 6 | 5 | 2 | 166 |
 | Alira Health Where Empathy Meets Science to Accelerate Life Sciences Research Alira Health is a global healthcare firm whose mission is to humanize healthcare and life sciences in partnership with patients. From development to medical care, we complement the expertise of our Pharma, Biotech, and MedTech clients with a full spectrum of services across their entire solutions lifecycle, including clinical operations, real-world evidence, and patient-centric technology offerings. Our integrated and multidisciplinary team of over 800 scientists, strategists, economists, clinicians, and biostatisticians collaborate across our North American, European, and Asian offices and advise 80% of the top 50 MedTech companies and 75% of … Type: | 8 | 1 | 2 | 619 |
 | ILIFE CONSULTING A reliable partner for clinical development, we synchronize endpoints with funding milestones, ensuring impactful trials 🤝 ILife Consulting is an entrepreneurial clinical partner specializing in providing tailored support for innovative, emerging life science companies. With about 20 active clients, including prominent Biotech companies and prestigious clinical sites such as Imcheck, Peptinov, Carthera, Smart Immune, Gustave Roussy, and Surgimab, who rely on our expertise, we are committed to making your clinical development genuinely fit for your purpose. We create tailored plans for each partner based on their specific needs, including study design, budget planning, and financing strategies. Our strength lies in … Type: | 4 | 0 | 2 | 15 |
 | ELITYS [Automatic translation follows] A new experience of the Council Elitys has been supporting its clients in their projects in Industry and Life Science for over 15 years. From industrialization to continuous improvement, our engineers work in close collaboration with the internal teams of partner companies. Type: | 2 | 0 | 2 | 249 |
 | Igyxos Igyxos develop more effective/efficient infertility treatment for patients Igyxos is a biotechnology company based out of CENTRE INRAe VAL DE LOIRE SITE DE TOURS, NOUZILLY, France. Biotechnologie, Fertilité, and anticorps monoclonal Tags: FrenchTech120 Type: | 2 | 1 | 2 | 10 |
 | ProductLife Group ProductLife Group’s mission is to improve human health by delivering regulatory compliance services for the safe and effective use of medical solutions. Since almost 30 years, PLG supports clients through the entire product life cycle, combining local expertise with global reach spanning more than 130 countries. It provides consulting and outsourcing services in the areas of regulatory affairs, quality and compliance, vigilances and medical information, covering both established products and innovative therapeutics & diagnostics. With a goal of continuously improving the value delivered to people and customers, PLG is committed to long-term partnership, innovation, flexibility, and cost efficiency. Data Management, … Type: | 4 | 2 | 2 | 1,106 |
 | Mnemo Therapeutics Mnemo Therapeutics is a biotechnology company focused on discovering and developing immune based therapies, including powerful cell therapies, that create accessible cures for solid tumors and blood cancers. Its EnfiniT platform, a groundbreaking drug discovery engine, leverages a new class of antigens with greater tumor specificity and a suite of technologies to significantly improve T cell memory, persistence, and sensitivity. The result is dramatic improvement in the body’s immune response to overcome disease. Mnemo is built by a global team of scientists and biotech leaders united in their mission to create the most powerful immune therapies to deliver accessible cures … Tags: FrenchTech120 Type: | 4 | 3 | 2 | 41 |
 | Home Biosciences A new breed of biotech company A new breed of biotech company aiming to unlock scientific breakthrough by leveraging an asset-centric operating model Type: | 5 | 4 | 2 | 9 |
 | AlgoTx AlgoTx develops novel therapeutic solutions for complex pain AlgoTherapeutix (AlgoTx) is a clinical stage biotechnology company developing targeted, first in class therapeutics for peripheral neuropathic pain. Its lead asset, ATX01, is based on a topical reformulation of amitriptyline with two lead indications of high unmet need that lead to unbearable pain in patient’s extremities and for which there are currently no viable treatment options. ATX01 targets the signaling pathways involved in the regulation of pain by inhibiting specific nociceptive sodium channel receptors. Its topical administration provides targeted pain relief from the excruciating pain in patient’s extremities for its two lead … Type: | 4 | 3 | 2 | 13 |
 | Arsen Cybersecurity Human risk managed the right way Arsen is a phishing training and awareness solution, leveraging realistic simulation, microlearning and reporting. Cybersécurité, SaaS, Phishing, Cybersecurity Awareness, and human risks Type: | 8 | 5 | 2 | 18 |
 | Meccellis Biotech French manufacturer of biologic implants Meccellis Biotech is a company expert in Tissue and Cell Engineering with a diversified offer for multiple surgical specialties. After 7 years of marketing, Meccellis Biotech is now present in 25 countries. The passion and professionalism of its teams have made of Meccellis Biotech, a reference company for the manufacturing of biomaterials. For any further information you may need regarding our range of biologic implants, please feel free to contact us: contact@meccellis.com - Phone number: +33 (0) 5 17 81 07 63 - THE MECCELLIS BIOTECH TEAM Breast reconstruction: CELLIS Breast, General surgery: CELLIS, and … Type: | 5 | 1 | 2 | 10 |
 | Gapianne [Automatic translation follows] The first French platform for intimate well-being for women. Let's reinvent women's intimacy. Gapianne is the first French intimate well-being platform designed by women for women. Libido, hormones, postpartum, menopause, periods... A new holistic and caring approach to these subjects which concern us all via an eshop, expert masterclasses and educational advice. It is high time to consider intimacy and sexuality as an act of well-being and self-care. Beauty, Intimacy, Ecommerce, Wellness, Well-being, Intimacy, Perineum, Femininity, Health, femtech, health, women health, women's health, and Intimate well-being Type: | 5 | 3 | 2 | 6 |
 | epilab A screening point-of-care test for Tuberculosis : an unmet need to eradicate tuberculosis epilab's screening test helps health organization who wants to fight tuberculosis by bridging the diagnosis gap in developing countries and downscaling tuberculosis infections and victims. Type: | 10 | 8 | 2 | 5 |
 | Citeline Citeline powers a full suite of complementary business intelligence offerings to meet the evolving needs of health care professionals to accelerate the connection of treatments to patients and patients to treatments. These patient-focused solutions and services deliver and analyze data used to drive clinical, commercial and regulatory-related decisions and create real-world opportunities for growth. Our global teams of analysts, journalists and consultants keep their fingers on the pulse of the pharmaceutical, biomedical and medtech industries, covering it all with expert insights: key diseases, clinical trials, drug R&D and approvals, market forecasts and more. Type: | 12 | 10 | 2 | 420 |
 | PTC Therapeutics, Inc. We're committed to a single purpose: Extending life’s moments for patients with rare diseases and their loved ones. PTC is a science-driven, patient-centered biopharmaceutical company focused on discovering, developing & commercializing medicine for patients with rare and serious disease. Orphan and Ultra-orphan Disorders, Oncology, and Anti-infectives Type: | 3 | 1 | 2 | 1,230 |
 | Orphalan At Orphalan we strive to develop rare disease treatments to improve patients lives. Transforming Rare Disease Treatment At Orphalan we identify, develop, and provide access to innovative treatments for patients with rare diseases to make a positive and meaningful difference. | 3 | 2 | 2 | 105 |
 | Altevax Biotech Altevax is developing a disruptive immunotherapy technology against cancer Altevax is developing a powerful pioneering immunotherapy technology against cancer. Its patented melanin-based technology has been proven in pre-clinical trials to boost an antigen-specific immune response with Cytotoxic T-lymphocytes (CD8+ Killer T cells), the body’s most powerful defenders. The Altevax immunotherapy technology works with a wide range of peptides. The Altevax technology is complementary to other anti-cancer immune technologies, such as anti PD1s. Altevax is developing an immunotherapy against glioblastoma, currently in advanced pre-clinical development, with Phase 1/2a expected in early 2024. Altevax's partnership with Assistance Publique Hôpitaux de Paris and … Type: | 3 | 1 | 2 | 6 |
 | Tech2heal Humanizing Healthcare We build digital solutions to reshape the healthcare system. Make health accessible to all through a patient-centric & data-driven approach. health tech, digital health, mental health, Artificial Intelligence, and Care Pathways Type: | 6 | 3 | 2 | 9 |
 | Mereo BioPharma Mereo BioPharma is a clinical-stage company focused on developing & commercialising rare disease & oncology treatments. Welcome to Mereo BioPharma, we are an agile biopharmaceutical company, focused on finding and bringing to market therapies that will improve the lives of people living with a rare disease. We are driven by a true understanding of the critical nature of our mission. We harness the power of science; with our knowledge of the rare diseases we seek to treat and deep relationships with all our stakeholders to create new therapeutic possibilities for people who need them. We do this in a focused … Type: | 3 | 0 | 2 | 43 |
 | Medelse [Automatic translation follows] Platform for connecting health establishments and liberal professionals Medelse supports health establishments (public and private) by offering them an additional pool of reinforcements to counter the shortage of caregivers: liberal professionals. Thanks to Medelse, self-employed caregivers (nurses, doctors, midwives and masseurs-physiotherapists), via their mobile application, can accept missions to work for a few days per month, on an ad hoc and/or recurring basis in our partner health establishments. . Our mission: to provide a turnkey solution to healthcare establishments so that all patients in hospitals, clinics (and others) and all residents of nursing homes and medico-social establishments … Type: | 3 | 2 | 2 | 24 |
 | SUPERBRANCHE Nanomaterials as Nanomedicines: let's play collective! SUPERBRANCHE : Nanomedicine as a breakthrough to treat cancer We bring answers to the following issue: intratumoral injection of nanomaterials implying both accessibility and detection of the tumor beforehand. We position ourselves as a producer dedicated to the synthesis of architectured nanomaterials as simple as possible and of controlled size. Our modular technology platform presents both therapeutic and diagnosis applications. It consists in a magnetic nanoparticle coated by a tailor made branched architecture. Thanks to their optimized shape and stability, our compounds are well tolerated and can be administered intravenously, thus helping to the … Type: | 10 | 6 | 2 | 9 |
 | ID SOLUTIONS ID SOLUTIONS offers comprehensive Molecular Typing Assays using DigitalPCR for Oncology Diagnostics Our mission To provide innovative, reliable and standardized tools for oncology diagnostic. Research on circulating DNA from liquid biopsy, tumor DNA from solid biopsies. Our team is of molecular biology specialists with more than 20 years of expertise in nucleic acid extraction, molecular biology and oncology. Our proposals To offer a complete molecular typing solution, standardized operating procedures and custom development to improve diagnosis in oncology. biologie moléculaire, diagnostic oncologique, ADN circulant, biopsie liquide, PCR, Digital PCR, Multiplexing, Covid-19, and SARS-CoV-2 | 4 | 2 | 2 | 83 |
 | BRIC-BoRdeaux Institute of onCology Cliniciens et chercheurs réunis à Bordeaux pour la recherche contre le cancer. Unité de recherche sous les tutelles Inserm et Université de Bordeaux, composée de 11 équipes de recherche sur la thématique cancer : Team A. Bikfalvi / L. Brisson / T. Mathivet Tumor and vascular biology laboratory. Team M. Khatib / F. Delom Reprogramming tumor activity and associated microenvironment (RYTME). Team V. Moreau / F. Saltel Liver cancers and tumor invasion (LCTI). Team C. Varon Helicobacter- associated digestive cancers, cancers stem cells and therapeutic strategies. Team H. Rezvani / M. Beylot Barry Translational Research in Oncodermatology and orphan skin … Type: | 20 | 1 | 2 | 66 |
 | Aurora Sterilisation Bringing the highest sanitary safety and environmental quality for medical devices Aurora introduces the first non-toxic low temperature plasma sterilator for medical and research purposes : the Aqsaniit. -6log micro-organisms in 60 min, at no more than 40°C, with a patented sterile bag. Sterilisation, Plasma, and Low temperature Type: | 7 | 5 | 2 | 16 |
 | Aliri Revealing Biological secrets Aliri is committed to solving industry challenges by bringing innovative bioanalysis and spatial solutions to biotech and pharma, as the complexity of the drug development landscape continues to rise. Our mission is to support our customers with bringing life-saving therapies to market with speed and agility. We are focused on providing pharma and biotech companies with bioanalysis lab, spatial bioanalysis, and spatial biology solutions that will bring unique, comprehensive data to enable strategic decision making for lead optimization and strengthen regulatory submissions. MALDI Imaging, ADME analysis, Mass Spectrometry Imaging, Preclinical services, Molecular Imaging, Biodistribution, Pharmacokinetics, Biomarker Discovery, … Type: | 8 | 5 | 3 | 156 |
Startup